These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 28106934)

  • 1. Neuroimaging the neural correlates of increased risk for substance use disorders in attention-deficit/hyperactivity disorder-A systematic review.
    Adisetiyo V; Gray KM
    Am J Addict; 2017 Mar; 26(2):99-111. PubMed ID: 28106934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reward-Based Learning as a Function of Severity of Substance Abuse Risk in Drug-Naïve Youth with ADHD.
    Parvaz MA; Kim K; Froudist-Walsh S; Newcorn JH; Ivanov I
    J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):547-553. PubMed ID: 29924634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis.
    van Emmerik-van Oortmerssen K; van de Glind G; van den Brink W; Smit F; Crunelle CL; Swets M; Schoevers RA
    Drug Alcohol Depend; 2012 Apr; 122(1-2):11-9. PubMed ID: 22209385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk behaviours among substance use disorder treatment seekers with and without adult ADHD symptoms.
    Kaye S; Gilsenan J; Young JT; Carruthers S; Allsop S; Degenhardt L; van de Glind G; van den Brink W
    Drug Alcohol Depend; 2014 Nov; 144():70-7. PubMed ID: 25193717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder].
    Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Daigre Blanco C; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; González RA; Grau-López L; Groenman AP; Hemphälä M; Icick R; Johnson B; Kaess M; Kapitány-Fövény M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Ramos-Quiroga JA; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstädt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
    Z Kinder Jugendpsychiatr Psychother; 2021 Jan; 50(1):54-67. PubMed ID: 34397296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining the association between attention deficit hyperactivity disorder and substance use disorders: A familial risk analysis.
    Yule AM; Martelon M; Faraone SV; Carrellas N; Wilens TE; Biederman J
    J Psychiatr Res; 2017 Feb; 85():49-55. PubMed ID: 27835739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of family history of substance use disorder on reward processing in adolescents with and without attention-deficit/hyperactivity disorder.
    Paraskevopoulou M; van Rooij D; Schene AH; Batalla A; Chauvin RJ; Buitelaar JK; Schellekens AFA
    Addict Biol; 2022 Mar; 27(2):e13137. PubMed ID: 35229951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.
    Ottosen C; Petersen L; Larsen JT; Dalsgaard S
    J Am Acad Child Adolesc Psychiatry; 2016 Mar; 55(3):227-34.e4. PubMed ID: 26903256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Utility of the CPT in the Diagnosis of ADHD in Individuals with Substance Abuse: A Systematic Review.
    Slobodin O
    Eur Addict Res; 2020; 26(4-5):283-294. PubMed ID: 32535592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications.
    Schubiner H
    CNS Drugs; 2005; 19(8):643-55. PubMed ID: 16097847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of substance misuse on reward-processing in patients with attention-deficit/hyperactivity disorder.
    Paraskevopoulou M; van Rooij D; Batalla A; Chauvin R; Luijten M; Schene AH; Buitelaar JK; Schellekens AFA
    Neuropsychopharmacology; 2021 Feb; 46(3):622-631. PubMed ID: 33184474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders.
    Fatseas M; Debrabant R; Auriacombe M
    Curr Opin Psychiatry; 2012 May; 25(3):219-25. PubMed ID: 22449768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Substance Misuse and Family History of Substance Use Disorder on Delay Discounting in Adolescents and Young Adults with Attention-Deficit/Hyperactivity Disorder.
    Paraskevopoulou M; van Rooij D; Schene AH; Scheres APJ; Buitelaar JK; Schellekens AFA
    Eur Addict Res; 2020; 26(4-5):295-305. PubMed ID: 32659779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The International Collaboration on ADHD and Substance Abuse (ICASA): Mission, Results, and Future Activities.
    Van de Glind G; Brynte C; Skutle A; Kaye S; Konstenius M; Levin F; Mathys F; Demetrovics Z; Moggi F; Ramos-Quiroga JA; Schellekens A; Crunelle C; Dom G; van den Brink W; Franck J
    Eur Addict Res; 2020; 26(4-5):173-178. PubMed ID: 32599579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personality characteristics of adults with autism spectrum disorders or attention deficit hyperactivity disorder with and without substance use disorders.
    Sizoo B; van den Brink W; Gorissen van Eenige M; van der Gaag RJ
    J Nerv Ment Dis; 2009 Jun; 197(6):450-4. PubMed ID: 19525746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical exploration of co-occurring Attention-Deficit/Hyperactivity Disorder, mood disorder and Substance Use Disorder.
    Regnart J; Truter I; Meyer A
    Expert Rev Pharmacoecon Outcomes Res; 2017 Jun; 17(3):275-282. PubMed ID: 28686107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance use disorder and ADHD: is ADHD a particularly "specific" risk factor?
    Kousha M; Shahrivar Z; Alaghband-Rad J
    J Atten Disord; 2012 May; 16(4):325-32. PubMed ID: 22127397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Diagnosis in Patients with Substance Use Disorder and/or Attention-Deficit/Hyperactivity Disorder Using Continuous Performance Test.
    Slobodin O; Blankers M; Kapitány-Fövény M; Kaye S; Berger I; Johnson B; Demetrovics Z; van den Brink W; van de Glind G
    Eur Addict Res; 2020; 26(3):151-162. PubMed ID: 32074617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attention deficit hyperactivity disorder and dual disorders. Educational needs for an underdiagnosed condition.
    Martinez-Raga J; Szerman N; Knecht C; de Alvaro R
    Int J Adolesc Med Health; 2013; 25(3):231-43. PubMed ID: 23846135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues.
    Wilens TE
    Psychiatr Clin North Am; 2004 Jun; 27(2):283-301. PubMed ID: 15063998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.